Tarsus Pharmaceuticals has completed its acquisition of Alkeus Pharmaceuticals pursuant to a merger agreement dated July 31, 2026. This filing serves as an amendment to the initial current report and includes the historical audited financial statements of Alkeus for fiscal years ended September 30, 2025 and 2024, unaudited interim financials for periods ending June 30, 2026, and pro forma consolidated financial information. Tarsus Pharmaceuticals operates in the pharmaceutical industry.
